New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
06:02 EDTAVNRAvanir upgraded to Buy from Neutral at Mizuho
Mizuho upgraded Avanir Pharmaceuticals to Buy citing the Nuedexta patent case victory and the company's pipeline. The firm doubled its price target for shares to $10 from $5.
News For AVNR From The Last 14 Days
Check below for free stories on AVNR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
09:18 EDTAVNRFDA accepts Avanir's IND application for Phase II study for AVP-786
Subscribe for More Information
July 16, 2014
09:13 EDTAVNRAvanir's Nuedexta shows positive early results in clinical study of Alzheimer's
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use